Anna-Polina Shurygina - Search Results

Year	Number of Results
2009	2
2013	1
2014	1
2015	2
2019	1
2021	3
2022	2
2023	3
2024	1

1

How the immune mousetrap works: Structural evidence for the immunomodulatory action of a peptide from influenza NS1 protein.

Zabrodskaya Y, Tsvetkov V, Shurygina AP, Vasyliev K, Shaldzhyan A, Gorshkov A, Kuklin A, Fedorova N, Egorov V. Zabrodskaya Y, et al. Among authors: shurygina ap. Biophys Chem. 2024 Apr;307:107176. doi: 10.1016/j.bpc.2024.107176. Epub 2024 Jan 9. Biophys Chem. 2024. PMID: 38219420

2

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.

Pulkina A, Vasilyev K, Muzhikyan A, Sergeeva M, Romanovskaya-Romanko E, Shurygina AP, Shuklina M, Vasin A, Stukova M, Egorov A. Pulkina A, et al. Among authors: shurygina ap. Int J Mol Sci. 2023 Jul 14;24(14):11445. doi: 10.3390/ijms241411445. Int J Mol Sci. 2023. PMID: 37511205 Free PMC article.

3

Preclinical Evaluation of TB/FLU-04L-An Intranasal Influenza Vector-Based Boost Vaccine against Tuberculosis.

Shurygina AP, Zabolotnykh N, Vinogradova T, Khairullin B, Kassenov M, Nurpeisova A, Sarsenbayeva G, Sansyzbay A, Vasilyev K, Buzitskaya J, Egorov A, Stukova M. Shurygina AP, et al. Int J Mol Sci. 2023 Apr 18;24(8):7439. doi: 10.3390/ijms24087439. Int J Mol Sci. 2023. PMID: 37108602 Free PMC article.

4

SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.

Stanevich OV, Alekseeva EI, Sergeeva M, Fadeev AV, Komissarova KS, Ivanova AA, Simakova TS, Vasilyev KA, Shurygina AP, Stukova MA, Safina KR, Nabieva ER, Garushyants SK, Klink GV, Bakin EA, Zabutova JV, Kholodnaia AN, Lukina OV, Skorokhod IA, Ryabchikova VV, Medvedeva NV, Lioznov DA, Danilenko DM, Chudakov DM, Komissarov AB, Bazykin GA. Stanevich OV, et al. Among authors: shurygina ap. Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x. Nat Commun. 2023. PMID: 36627290 Free PMC article.

5

A New Intranasal Influenza Vector-Based Vaccine TB/FLU-04L Against Tuberculosis: Preclinical Safety Studies.

Buzitskaya Z, Stosman K, Khairullin B, Kassenov M, Nurpeisova A, Abylai Sansyzbay A, Shurygina AP, Aleksandrov A, Sivak K, Stukova M. Buzitskaya Z, et al. Among authors: shurygina ap. Drug Res (Stuttg). 2022 Jun;72(5):255-258. doi: 10.1055/a-1785-3936. Epub 2022 Mar 22. Drug Res (Stuttg). 2022. PMID: 35318622

6

Enhancement of the Local CD8⁺ T-Cellular Immune Response to Mycobacterium tuberculosis in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens.

Vasilyev K, Shurygina AP, Zabolotnykh N, Sergeeva M, Romanovskaya-Romanko E, Pulkina A, Buzitskaya J, Dogonadze MZ, Vinogradova TI, Stukova MA. Vasilyev K, et al. Among authors: shurygina ap. Vaccines (Basel). 2021 Nov 3;9(11):1273. doi: 10.3390/vaccines9111273. Vaccines (Basel). 2021. PMID: 34835204 Free PMC article.

7

CRISPR-Cas9 mediated knockout of AnxA6 gene enhances influenza A virus replication in low-permissive HEK293FT cell line.

Komissarov A, Sergeeva M, Zhuravlev E, Medvedev S, Malakhova A, Andreeva E, Shurygina AP, Gorshkov A, Timofeeva M, Balakhonova E, Grudinin M, Zakian S, Richter V, Stepanov G. Komissarov A, et al. Among authors: shurygina ap. Gene. 2022 Jan 30;809:146024. doi: 10.1016/j.gene.2021.146024. Epub 2021 Oct 19. Gene. 2022. PMID: 34673207

8

Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.

Vasilyev K, Shurygina AP, Sergeeva M, Stukova M, Egorov A. Vasilyev K, et al. Among authors: shurygina ap. Microorganisms. 2021 Mar 26;9(4):690. doi: 10.3390/microorganisms9040690. Microorganisms. 2021. PMID: 33810549 Free PMC article.

9

Meglumine acridone acetate, the ionic salt of CMA and N-methylglucamine, induces apoptosis in human PBMCs via the mitochondrial pathway.

Plotnikova MA, Klotchenko SA, Kiselev AA, Gorshkov AN, Shurygina AS, Vasilyev KA, Uciechowska-Kaczmarzyk U, Samsonov SA, Kovalenko AL, Vasin AV. Plotnikova MA, et al. Sci Rep. 2019 Dec 3;9(1):18240. doi: 10.1038/s41598-019-54208-9. Sci Rep. 2019. PMID: 31796757 Free PMC article.

10

Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis.

Weiss R, Laengle J, Sachet M, Shurygina AP, Kiselev O, Egorov A, Bergmann M. Weiss R, et al. Among authors: shurygina ap. Antiviral Res. 2015 Nov;123:93-104. doi: 10.1016/j.antiviral.2015.09.005. Epub 2015 Sep 11. Antiviral Res. 2015. PMID: 26367324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year